Justin A Renz - Net Worth and Insider Trading
Justin A Renz Net Worth
The estimated net worth of Justin A Renz is at least $2 Million dollars as of 2024-09-20. Justin A Renz is the CFO of Ardelyx Inc and owns about 295,257 shares of Ardelyx Inc (ARDX) stock worth over $2 Million. Justin A Renz is also the EVP, CFO & Treasurer of Karyopharm Therapeutics Inc and owns about 19,173 shares of Karyopharm Therapeutics Inc (KPTI) stock worth over $14,188. Details can be seen in Justin A Renz's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Justin A Renz has not made any transactions after 2024-08-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Justin A Renz
Justin A Renz Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Justin A Renz owns 3 companies in total, including Ardelyx Inc (ARDX) , Karyopharm Therapeutics Inc (KPTI) , and EPIRUS Biopharmaceuticals Inc (EPRSQ) .
Click here to see the complete history of Justin A Renz’s form 4 insider trades.
Insider Ownership Summary of Justin A Renz
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ARDX | Ardelyx Inc | 2024-08-20 | Chief Financial Officer |
| KPTI | Karyopharm Therapeutics Inc | 2016-11-09 | EVP & Chief Financial Officer |
| EPRSQ | EPIRUS Biopharmaceuticals Inc | 2014-02-10 | EVP & CFO & Treasurer |
Justin A Renz Latest Holdings Summary
Justin A Renz currently owns a total of 2 stocks. Among these stocks, Justin A Renz owns 295,257 shares of Ardelyx Inc (ARDX) as of August 20, 2024, with a value of $2 Million and a weighting of 99.2%. Justin A Renz also owns 19,173 shares of Karyopharm Therapeutics Inc (KPTI) as of November 9, 2016, with a value of $14,188 and a weighting of 0.8%.
Latest Holdings of Justin A Renz
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ARDX | Ardelyx Inc | 2024-08-20 | 295,257 | 5.99 | 1,768,589 |
| KPTI | Karyopharm Therapeutics Inc | 2016-11-09 | 19,173 | 0.74 | 14,188 |
Holding Weightings of Justin A Renz
Justin A Renz Form 4 Trading Tracker
According to the SEC Form 4 filings, Justin A Renz has made a total of 19 transactions in Ardelyx Inc (ARDX) over the past 5 years, including 1 buys and 18 sells. The most-recent trade in Ardelyx Inc is the sale of 5,289 shares on August 20, 2024, which brought Justin A Renz around $30,994.
According to the SEC Form 4 filings, Justin A Renz has made a total of 0 transactions in Karyopharm Therapeutics Inc (KPTI) over the past 5 years. The most-recent trade in Karyopharm Therapeutics Inc is the sale of 4,342 shares on November 9, 2016, which brought Justin A Renz around $35,561.
Insider Trading History of Justin A Renz
- 1
Justin A Renz Trading Performance
GuruFocus tracks the stock performance after each of Justin A Renz's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Justin A Renz is 34.93%. GuruFocus also compares Justin A Renz's trading performance to market benchmark return within the same time period. The performance of stocks bought by Justin A Renz within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Justin A Renz's insider trading performs compared to the benchmark.
Performance of Justin A Renz
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 12.04 | | | | | |
| Relative Return to S&P 500(%) | 15.71 | | | | | |
Justin A Renz Ownership Network
Justin A Renz Owned Company Details
What does Ardelyx Inc do?
Who are the key executives at Ardelyx Inc?
Justin A Renz is the Chief Financial Officer of Ardelyx Inc. Other key executives at Ardelyx Inc include Chief Development Officer David P. Rosenbaum , director & President & CEO Michael Raab , and Chief Medical Officer Laura A Williams .
Ardelyx Inc (ARDX) Insider Trades Summary
Over the past 18 months, Justin A Renz made 7 insider transaction in Ardelyx Inc (ARDX) with a net sale of 249,427. Other recent insider transactions involving Ardelyx Inc (ARDX) include a net sale of 200,608 shares made by David P. Rosenbaum , a net sale of 288,827 shares made by Michael Raab , and a net sale of 490,778 shares made by Elizabeth A Grammer .
In summary, during the past 3 months, insiders sold 235,128 shares of Ardelyx Inc (ARDX) in total and bought 0 shares, with a net sale of 235,128 shares. During the past 18 months, 1,832,362 shares of Ardelyx Inc (ARDX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,832,362 shares.
Ardelyx Inc (ARDX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Ardelyx Inc Insider Transactions
Justin A Renz Mailing Address
Above is the net worth, insider trading, and ownership report for Justin A Renz. You might contact Justin A Renz via mailing address: C/o Karyopharm Therapeutics Inc., 85 Wells Avenue, Second Floor, Newton Ma 02459.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
